Clinical trial
Open-label, Single Arm, Interventional Study to Explore the Efficacy and Safety of Paliperidone ER in the Management of Patients With Acute Agitation and/or Aggression
NCT01050478 is registered in ClinicalTrials.gov with Janssen Cilag N.V./S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-label, Single Arm, Interventional Study to Explore the Efficacy and Safety of Paliperidone ER in the Management of Patients With Acute Agitation and/or Aggression
- Lead sponsor
- Janssen Cilag N.V./S.A.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- December 31, 2011
- Enrollment
- 56 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.